Literature DB >> 19329486

MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family.

Li F Chan1, Tom R Webb, Teng-Teng Chung, Eirini Meimaridou, Sadani N Cooray, Leonardo Guasti, J Paul Chapple, Michaela Egertová, Maurice R Elphick, Michael E Cheetham, Louise A Metherell, Adrian J L Clark.   

Abstract

The melanocortin receptor (MCR) family consists of 5 G protein-coupled receptors (MC1R-MC5R) with diverse physiologic roles. MC2R is a critical component of the hypothalamic-pituitary-adrenal axis, whereas MC3R and MC4R have an essential role in energy homeostasis. Mutations in MC4R are the single most common cause of monogenic obesity. Investigating the way in which these receptors signal and traffic to the cell membrane is vital in understanding disease processes related to MCR dysfunction. MRAP is an MC2R accessory protein, responsible for adrenal MC2R trafficking and function. Here we identify MRAP2 as a unique homologue of MRAP, expressed in brain and the adrenal gland. We report that MRAP and MRAP2 can interact with all 5 MCRs. This interaction results in MC2R surface expression and signaling. In contrast, MRAP and MRAP2 can reduce MC1R, MC3R, MC4R, and MC5R responsiveness to [Nle4,D-Phe7]alpha-melanocyte-stimulating hormone (NDP-MSH). Collectively, our data identify MRAP and MRAP2 as unique bidirectional regulators of the MCR family.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19329486      PMCID: PMC2661846          DOI: 10.1073/pnas.0809918106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Studies on the physiological functions of the melanocortin system.

Authors:  Roger D Cone
Journal:  Endocr Rev       Date:  2006-10-31       Impact factor: 19.871

2.  Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

3.  Common genetic variation near MC4R is associated with waist circumference and insulin resistance.

Authors:  John C Chambers; Paul Elliott; Delilah Zabaneh; Weihua Zhang; Yun Li; Philippe Froguel; David Balding; James Scott; Jaspal S Kooner
Journal:  Nat Genet       Date:  2008-05-04       Impact factor: 38.330

4.  Targeted disruption of the melanocortin-4 receptor results in obesity in mice.

Authors:  D Huszar; C A Lynch; V Fairchild-Huntress; J H Dunmore; Q Fang; L R Berkemeier; W Gu; R A Kesterson; B A Boston; R D Cone; F J Smith; L A Campfield; P Burn; F Lee
Journal:  Cell       Date:  1997-01-10       Impact factor: 41.582

5.  A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate.

Authors:  B L Brown; J D Albano; R P Ekins; A M Sgherzi
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

6.  The use of thyroglobulin to induce antigenicity to small molecules.

Authors:  W R Skowsky; D A Fisher
Journal:  J Lab Clin Med       Date:  1972-07

7.  Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2.

Authors:  Louise A Metherell; J Paul Chapple; Sadani Cooray; Alessia David; Christian Becker; Franz Rüschendorf; Danielle Naville; Martine Begeot; Bernard Khoo; Peter Nürnberg; Angela Huebner; Michael E Cheetham; Adrian J L Clark
Journal:  Nat Genet       Date:  2005-01-16       Impact factor: 38.330

8.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass.

Authors:  A S Chen; D J Marsh; M E Trumbauer; E G Frazier; X M Guan; H Yu; C I Rosenblum; A Vongs; Y Feng; L Cao; J M Metzger; A M Strack; R E Camacho; T N Mellin; C N Nunes; W Min; J Fisher; S Gopal-Truter; D E MacIntyre; H Y Chen; L H Van der Ploeg
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

9.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse.

Authors:  A A Butler; R A Kesterson; K Khong; M J Cullen; M A Pelleymounter; J Dekoning; M Baetscher; R D Cone
Journal:  Endocrinology       Date:  2000-09       Impact factor: 4.736

10.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.

Authors:  I Sadaf Farooqi; Julia M Keogh; Giles S H Yeo; Emma J Lank; Tim Cheetham; Stephen O'Rahilly
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

View more
  74 in total

1.  Regulation of G protein-coupled receptor signaling: specific dominant-negative effects of melanocortin 2 receptor accessory protein 2.

Authors:  Julien A Sebag; Patricia M Hinkle
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

Review 2.  Intracellular signaling mechanisms of the melanocortin receptors: current state of the art.

Authors:  Adriana R Rodrigues; Henrique Almeida; Alexandra M Gouveia
Journal:  Cell Mol Life Sci       Date:  2014-12-12       Impact factor: 9.261

Review 3.  Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.

Authors:  Markus Böhm; Susanne Grässel
Journal:  Endocr Rev       Date:  2012-06-26       Impact factor: 19.871

Review 4.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

Review 5.  Participation of the central melanocortin system in metabolic regulation and energy homeostasis.

Authors:  Jin Kwon Jeong; Jae Geun Kim; Byung Ju Lee
Journal:  Cell Mol Life Sci       Date:  2014-06-04       Impact factor: 9.261

6.  Identifying and Classifying Shared Selective Sweeps from Multilocus Data.

Authors:  Alexandre M Harris; Michael DeGiorgio
Journal:  Genetics       Date:  2020-03-09       Impact factor: 4.562

7.  Genomewide association studies of suicide attempts in US soldiers.

Authors:  Murray B Stein; Erin B Ware; Colter Mitchell; Chia-Yen Chen; Susan Borja; Tianxi Cai; Catherine L Dempsey; Carol S Fullerton; Joel Gelernter; Steven G Heeringa; Sonia Jain; Ronald C Kessler; James A Naifeh; Matthew K Nock; Stephan Ripke; Xiaoying Sun; Jean C Beckham; Nathan A Kimbrel; Robert J Ursano; Jordan W Smoller
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-09-13       Impact factor: 3.568

Review 8.  Malignant melanoma and melanocortin 1 receptor.

Authors:  A A Rosenkranz; T A Slastnikova; M O Durymanov; A S Sobolev
Journal:  Biochemistry (Mosc)       Date:  2013-11       Impact factor: 2.487

9.  Attenuated hypothalamic responses to α-melanocyte stimulating hormone during pregnancy in the rat.

Authors:  S R Ladyman; R A Augustine; E Scherf; H R Phillipps; C H Brown; D R Grattan
Journal:  J Physiol       Date:  2016-02-15       Impact factor: 5.182

10.  Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2.

Authors:  Teng-Teng L L Chung; Li F Chan; Louise A Metherell; Adrian J L Clark
Journal:  Clin Endocrinol (Oxf)       Date:  2009-06-24       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.